Merck

February 08, 2008 -- (ALBUQUERQUE) -- New Mexico Attorney General Gary King today announced thatNew Mexico will receive $716,071 as part of two separate global settlements totaling $649 million with Merck & Co., Inc. The settlements involve 49 states, the District of Columbia and the federal government.    » read more »

February 07, 2008 -- OLYMPIA - Washington Attorney General Rob McKenna in conjunction with 48 other states, the District of Columbia and the federal government, today announced a settlement with Merck & Co., Inc. Merck is the manufacturer of the drugs Zocor, Vioxx, and Pepcid. The announcement resolves allegations that the company failed to pay rebates due state Medicaid Programs under the Federal Medicaid Drug Rebate statute. Washington will receive more than $7.4 million as part of two separate global settlements totaling $649 million.    » read more »

February 7, 2008 -- The manufacturer of Zocor, Vioxx and Pepcid will pay Utah $2,256,337 for failing to give rebates to the state Medicaid program. Merck is paying a total of $649 million as part of two separate global settlements involving 49 states and the federal government.

“Merck is paying a great price for failing to be fair to taxpayers. I hope this will send a loud message to all pharmaceutical companies to play fair and pay up in the first place,” says Attorney General Mark Shurtleff.    » read more »

February 7, 2008 -- HARRISBURG - Pennsylvania Attorney General Tom Corbett today announced that Pennsylvania will receive more than $8.5 million as part of two separate national settlements with Merck & Co., over the pricing of various drugs, including Zocor, Vioxx and Pepcid.

The national settlements with Merck, totaling $649 million, involve 49 states, the District of Columbia and the federal government. The agreements resolve allegations that the company overcharged state Medicaid programs for these drugs.    » read more »

February 7, 2008 -- TRENTON - New Jersey Attorney General Anne Milgram announced today that New Jersey will receive $7.4 million in restitution in a Medicaid fraud settlement negotiated with pharmaceutical company Merck & Co., Inc.    » read more »

February 7, 2008 -- Carson City, NV— Nevada Attorney General Catherine Cortez Masto announced today the settlement of State of Nevada ex rel. Steinke v. Merck & Co., Inc., a civil fraud action brought under the Nevada False Claims Act. The lawsuit alleged that Merck overcharged the Medicaid program for prescriptions of Zocor and Vioxx to Nevada Medicaid recipients.    » read more »

February 7, 2008 -- Jefferson City, Mo. — Missouri Attorney General Jay Nixon today reached two settlements with pharmaceutical giant Merck that will provide $16 million in reimbursement for the Medicaid program. The settlements resolve allegations that Merck shortchanged rebates paid to the Medicaid program.    » read more »

February 07, 2008 -- BOSTON – Today, Massachusetts Attorney General Martha Coakley’s Officereached a settlement withMerck & Co., Inc, in which the Commonwealth’s Medicaid programwill receive $10,502,943as part of two separate global settlements totaling $649 million. The settlements involve the Attorneys General of 49 states and the District of Columbia, and the federal government.    » read more »

February 7, 2008 -- Maine Attorney General Steve Rowe today announced that Maine’s Medicaid program will receive approximately $2.2 million as part of two separate global settlements with Merck & Co., Inc.. The settlements involve 49 states, the District of Columbia and the federal government, totaling $649 million.

“This is a significant recovery for Maine’s Medicaid program,” Attorney General Rowe said.    » read more »

February 07, 2008 -- Kentucky Attorney General Jack Conway today announced that the Commonwealth of Kentucky will receive more than $1.4 million as part of two separate global settlements totaling $649 million with Merck & Co., Inc. The settlements involve 49 states, the District of Columbia and the federal government. Merck is the manufacturer of the drugs Zocor, Vioxx, and Pepcid.    » read more »

Feb. 7, 2008 -- Kansas Attorney General Steve Six today announced that Kansas will receive nearly $5 million as part of two separate global settlements totaling $649 million with Merck & Co., Inc.. The settlements involve 49 states, the District of Columbia and the federal government.    » read more »

February 7, 2008 -- Chicago - Illinois Attorney General Lisa Madigan today announced that the State of Illinois will receive $18.5 million as part of two separate global settlements totaling $649 million with Merck & Co., Inc., and involving 49 states, the District of Columbia and the federal government.    » read more »

February 7, 2008 -- Georgia Attorney General Thurbert Baker today announced that Georgia will receive $17.4 million as part of two separate global settlements totaling $649 million with Merck & Co., Inc.. The settlements involve 49 states, the District of Columbia and the federal government, and concern the Merck drugs Zocor, Vioxx, and Pepcid. The agreements with Merck resolve allegations that the company failed to pay rebates due state Medicaid Programs under the Federal Medicaid Drug Rebate statute.    » read more »

McCollum’s new civil enforcement bureau helps negotiate settlements resolving allegations that Merck failed to pay rebates due to state Medicaid programs

February 7, 2008 -- TALLAHASSEE, FL – Florida Attorney General Bill McCollum today announced that Florida will receive a total of $32.8 million as part of two separate global settlements totaling $649 million with Merck & Co., Inc. The settlements resolve allegations that the company failed to pay rebates for at least three prescription drugs due to state Medicaid Programs under the Federal Medicaid Drug Rebate statute.    » read more »

Launches Investigation of Vytorin Makers

NEW YORK, NY -- January 26, 2008 -‑ New York Attorney General Andrew M. Cuomo announced the service of wide-ranging subpoenas on Merck & Co. (NYSE: MRK), Schering-Plough Corp. (NYSE: SGP), and Merck/Schering-Plough Pharmaceuticals seeking information about Vytorin, advertised as a highly-effective, cholesterol-lowering drug. In a two-pronged investigation, Cuomo is seeking to determine whether the companies deliberately concealed the negative results of a research trial about the efficacy of Vytorin.    » read more »